Xconomy National

Archives

by in

Entry	Author	Date	Location
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer	Luke Timmerman	05/24/11	Seattle
Genentech Gears Up for ASCO, Pushing Data on Personalized Cancer Medicine	Luke Timmerman	05/18/11	San Francisco
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	04/28/11	San Diego
San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors	Bruce V. Bigelow	04/27/11	San Diego
San Diego VC Activity Falls 55 Percent, Ford Adopts Focus as EV “Tech Platform,” Verve Raises $3.5M, & More San Diego BizTech News	Bruce V. Bigelow	04/18/11	San Diego
West Wireless Health Institute Awards $10K Incentive Prize	Bruce V. Bigelow	04/13/11	San Diego
Bigger Isn’t Better: It’s Time for Big Pharma to Break Up Into Little Pharma	Luke Timmerman	03/28/11	National
Plexxikon, Creator of Hot Melanoma Drug, Bought by Daiichi Sankyo for $805M Upfront	Luke Timmerman	02/28/11	San Francisco
Amgen’s R&D Chief, Roger Perlmutter, on Why BioVex’s Cancer-Fighting Virus Is Worth $1B	Luke Timmerman	01/26/11	Boston
Plexxikon Cancer Drug Extends Lives, Med Devices Lose Swagger, Amgen Sells Fremont Facility, & More Bay Area Life Sciences News	Luke Timmerman	01/21/11	San Francisco
Plexxikon, Roche Drug Extends Lives in Patients With Deadly Skin Cancer	Luke Timmerman	01/19/11	San Francisco
E-Commerce Pioneer Sets Up Cancer Commons, Affymax Hires New Boss, Plexxikon Opts In, & More Bay Area Life Sciences News	Luke Timmerman	01/07/11	San Francisco
Plexxikon Opts to Co-Promote with Genentech	Luke Timmerman	01/06/11	San Francisco
Internet Commerce Pioneer Seeks to Crack Secretive Culture With Cancer Commons	Luke Timmerman	01/04/11	San Francisco
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move	Luke Timmerman	11/08/10	Seattle
Bristol-Myers Almost Ready to Seal the Deal, Complete Takeover of ZymoGenetics	Luke Timmerman	10/08/10	Seattle
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News	Luke Timmerman	09/30/10	Seattle
ZymoGenetics Melanoma Drug Shows Survival Data, Adding More Juice to Bristol’s Pipeline	Luke Timmerman	09/29/10	Seattle
iPierian Entices Corporate VCs, Plexxikon’s One-Two Punch, Jennerex’s Road Less Traveled, & More Bay Area Life Sciences News	Luke Timmerman	09/10/10	San Francisco
Jennerex, Charging Ahead With Tumor-Killing Virus, Follows Biotech Road Less Traveled	Luke Timmerman	09/09/10	San Francisco
Plexxikon Shows How New Drug Hits Molecular Target for Deadly Skin Cancer	Luke Timmerman	09/07/10	San Francisco
A Bidding War for 3Par, a Trademark War over Mafia Wars, a Barrage of New Y Combinator Startups, & More Bay Area BizTech and Life Sciences News	Wade Roush	08/30/10	San Francisco
Promising Skin Cancer Drug Could Be First Big Win for Plexxikon’s Structure-Based Drug Discovery Approach	Wade Roush	08/26/10	San Francisco
After the Meltdown: Synta Pharma CEO Trumpets New Top Cancer Drug	Ryan McBride	07/12/10	Boston
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News	Luke Timmerman	06/11/10	Seattle
Bezos Family Pledges $10M to the “Hutch” for Next-Generation Cancer Therapies	Luke Timmerman	11/23/09	Seattle
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus	Luke Timmerman	11/10/09	Boston
Zymo Melanoma Drug Shrinks Tumors	Luke Timmerman	05/13/09	Seattle
Synta Melanoma Drug Fails Disastrously in Clinical Trial, As Patients Show Higher Death Rate	Luke Timmerman	02/26/09	Boston
Synta Melanoma Data Coming in May	Luke Timmerman	02/02/09	Boston
Page 1 of 2	next page »